The conceptual 'Plug & Play' wearable injector has been designed by Cambridge Consultants and David Robinson as a healthcare solution that would revolutionize the process of administering medication.
The wearable maintains a compact design that could be adhered onto the skin and have a vial of medication positioned into the awaiting chamber before pressing the play button to start the administration process. Users would know how the process is going thanks to the color coded design that would offer feedback during the entire period.
The conceptual 'Plug & Play' wearable injector could help to reduce the anxiety for patients who require constant doses of medication and would also put more control in their hands by allowing them to administer it on their own terms.
Wearable Drug Delivery Patches
The 'Plug & Play' Wearable Injector Optimizes Drug Delivery
Trend Themes
1. Wearable Drug Delivery - The development of wearable drug delivery devices that enable patients to administer their own medication safely and effectively presents a significant disruptive innovation opportunity for the healthcare industry.
2. Smart Adherence Technology - The use of smart, wearable technology to promote and monitor patient adherence to medication regimens represents a major disruptive innovation opportunity in the healthcare sector.
3. Personalized Drug Delivery - The move towards personalized medicine, including the development of personalized drug delivery methods, presents a significant opportunity for innovation in the pharmaceutical industry.
Industry Implications
1. Healthcare - The development of innovative drug delivery solutions presents opportunities for disruption in the healthcare sector, including patient self-administration of medication and improved adherence to treatment plans.
2. Pharmaceuticals - The growth of wearables and smart adherence technology presents opportunities for pharmaceutical companies to develop new drug delivery solutions tailored to meet the evolving needs of patients.
3. Medical Device - The design and manufacture of wearable drug delivery systems represent a significant disruptive innovation opportunity for medical device companies looking to develop innovative solutions for patients and healthcare providers.